CHICAGO--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the investigational IMPROVE-IT study met its primary and all secondary composite ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — The addition of ezetimibe to simvastatin was associated with better clinical outcomes in high-risk ...

March 20, 2006 (Atlanta) — A combination of the cholesterol-lowering drugs ezetimibe and simvastatin is more effective at lowering C-reactive protein (CRP) levels than simvastatin alone, a post-hoc ...

SaveHealth reports on popular statin medications that lower cholesterol and cardiovascular risks, highlighting their benefits ...

Efficacy of switching statin therapy from generic simvastatin was examined in a VA population. Ezetimibe/simvastatin was more potent than atorvastatin or rosuvastatin in lowering LDL. Treatment of ...

Early Communication about an Ongoing Data Review for Ezetimibe/Simvastatin (marketed as Vytorin), Ezetimibe (marketed as Zetia), and Simvastatin (marketed as Zocor) This communication is based on ...

CHICAGO, IL—Addition of the cholesterol-lowering agent ezetimibe to statin therapy decreases cardiovascular events compared with what can be achieved with a statin alone, according to results of the ...

The results of 2 studies presented at the 2006 symposium of the International Society of Atherosclerosis in Rome, Italy, have demonstrated the benefit of adding the cholesterol absorption inhibitor ...

SHARP is the First and Only Prospective Clinical Study in Patients With Chronic Kidney Disease to Show That an LDL Cholesterol-Lowering Medicine Reduced Major Vascular and Atherosclerotic Events "This ...

HealthDay News— For patients with hypercholesterolemia, simvastatin is superior to ezetimibe for producing lymphocyte-suppression and systemic anti-inflammatory and endothelial protective effects, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio CHICAGO — The addition of ezetimibe to ...